Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05288517 · ClinicalTrials.gov registry record · NA
A Randomized Control Trial of a Digital Health Tool
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 20,131
- Enrollment target
NCT05288517: Completed NA study, sponsored by Kaiser Permanente.
NCT05288517 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 20,131 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1335% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05288517, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 20,131 participants
- Enrollment target
Study Summary
This randomized trial evaluated whether sending population-based invitation messages through the electronic health record to visit Lock to Live (L2L), a web-based decision aid that incorporates patients' values into recommendations for safe storage of firearms and medications, impacted readiness to change firearm and medication storage behaviors.
Primary Outcome
Patient reported readiness to change safe storage behavior for firearms and medications.
Interventions
- BEHAVIORAL Lock to Live
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,131 participants |
| Start Date | 2021-04-19 |
| Est. Completion | 2022-03-01 |
| Phase | NA |
What the finished NCT05288517 record still lists
NCT05288517 is an interventional study that assigns participants to a tested intervention. Its 20,131 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1335% higher).
The record links to 0 conditions, and to 1 intervention - of which Lock to Live is the first listed.
NCT05288517 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05288517 about?
NCT05288517 is a clinical study titled "A Randomized Control Trial of a Digital Health Tool". This randomized trial evaluated whether sending population-based invitation messages through the electronic health record to visit Lock to Live (L2L), a web-based decision aid that incorporates patients' values into recommendations for safe storage of firearms and medications, impacted readiness to ...
What is the current status of trial NCT05288517?
This trial is currently completed. It is a NA study. The enrollment target is 20,131 participants. The study started on 2021-04-19. Estimated completion is 2022-03-01.
What interventions are being tested in trial NCT05288517?
The interventions under investigation include: Lock to Live (BEHAVIORAL).
Who is sponsoring clinical trial NCT05288517?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05288517's enrollment target sits among peer trials
20,131 11th of 2000 higher than 1,990 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI